NIKA PHARMACEUTICALS, INC
Datakwaliteit: 83%
NIKA
OTC
Manufacturing
Chemicals
€ 0,75
€ 0,00
(0,00%)
Marktkapitalisatie: 785,03 M
Prijs
€ 0,75
Marktkapitalisatie
785,03 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—
Quick Summary
Belangrijkste Punten
Negative free cash flow of -79.654,0
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROIC-218,55%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio0,08
Interest CoverageN/A
Waardering
PE (TTM)
-10275,58
Onder sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1366 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1366 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -10275,6 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -53,5 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
Geen toekomstige schattingen beschikbaar
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -76.398,0 |
| ROE | N/A | ROA | -276,64% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -79.654,0 |
| ROIC | -218,55% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,08 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | -260.539 | Tangible Book Value | -260.539 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -10275,58 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -0,01% | ||
| Market Cap | 785,03 M | Enterprise Value | 785,31 M |
| Per Share | |||
| EPS (Diluted TTM) | 0,00 | Revenue / Share | N/A |
| FCF / Share | 0,00 | OCF / Share | 0,00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 104,26% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Revenue | — | 0,0 | 0,0 | 0,0 | — |
| Net Income | -76.398,0 | -95.792,0 | -64.833,0 | -3,18 M | -8.907,0 |
| EPS (Diluted) | 0,00 | 0,00 | — | 0,00 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -76.398,0 | -95.792,0 | -64.833,0 | -3,18 M | -8.907,0 |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 20.996,0 | 17.934,0 | 19.596,0 | 864,0 | 1.611,0 |
| Total Liabilities | 318.624,0 | 239.164,0 | 101.745,0 | 18.180,0 | 10.518,0 |
| Shareholders' Equity | -297.628,0 | -221.230,0 | -82.149,0 | -17.316,0 | -8.907,0 |
| Total Debt | 318.624,0 | 239.164,0 | — | — | — |
| Cash & Equivalents | 1.889,0 | 2.083,0 | 19.596,0 | 864,0 | — |
| Current Assets | 20.996,0 | 17.934,0 | 19.596,0 | 864,0 | 1.611,0 |
| Current Liabilities | 318.624,0 | 239.164,0 | 101.745,0 | 18.180,0 | — |
{"event":"ticker_viewed","properties":{"ticker":"NIKA","listing_kind":"stock","pathname":"/stocks/nika","exchange":"OTC","country":"US"}}